Market Overview

Apple Price Target Raised 15% By Evercore, Sees Revenue Growth Resuming

Share:

Apple (NASDAQ: AAPL) moved slightly higher after seeing its price target was boosted 15 percent by an Evercore analyst who cited future growth related to its core iPhone and other products.

Apple shares have risen by a split-adjusted percent in the past year and traded recently at $93.73, up 0.22 percent.

Evercore's Rob Chira raised his Apple target from $100 to $115, predicting that revenue growth will "re-accelerate" into fiscal 2015. After three quarters of somewhat sluggish growth, Apple's revenue fell 20 percent in the most recently ended period, to $45.65 billion.

"We see Apple creating its own growth" based particularly on the iPhone, iWatch and iBand products, Cihra said in a note.

Apple's well-understood pursuit of higher-margin, higher-end products at the expense of losing a portion of the larger market seems likely to remain in place.

"We don't see Apple chasing the faster-growing low end" of the market, Cihra said. "By definition, it's why Apple holds premium gross margins."

Latest Ratings for AAPL

DateFirmActionFromTo
Jul 2019MaintainsOverweight
Jul 2019DowngradesNeutralSell
Jun 2019Initiates Coverage OnHold

View More Analyst Ratings for AAPL
View the Latest Analyst Ratings

Posted-In: Evercore Rob ChiraAnalyst Color Price Target Analyst Ratings

 

Related Articles (AAPL)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
UALMaintains120.0
OSTKReinstates34.0
PPGMaintains115.0
JBLUMaintains21.0
ALGTMaintains186.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

5-Star Biotech Stock Watch: Anacor Pharmaceuticals

Rumored Big Engine Order From American Could Boost GE Aviation's Bottom Line